FDA inspection
Aurobindo Pharma Limited: FDA inspection ending Oct 22, 2009
FDA inspection 633329 · Voluntary Action Indicated (VAI) · Bachupally
Key facts
| Inspection ID | 633329 |
|---|---|
| Firm | Aurobindo Pharma Limited |
| FEI number | 3004446312 |
| Address | Medchal - Malkajgiri District, Unit 12; Medchal |
| City | Bachupally |
| Fiscal year | 2010 |
| Inspection end date | Oct 22, 2009 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bio-Research Monit: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data